Combatting Corneal Steepening
A three-year study of progressive keratoconus has shown that corneal cross-linking is associated with sustained delay in disease progression.
Mark Hillen |
BSCVA, best spectacle-corrected visual acuity; CXL, corneal collagen cross-linking; D, diopters; IOP, intraocular pressure; PBO, placebo; R, randomization; UCVA, uncorrected visual acuity. †Comparison of trends over time.
Conclusions: CXL was associated with “sustained improvement in Kmax, UCVA and BSCVA”; disease progression occurred in control eyes.
- C. Wittig-Silva, E. Chan, F.M.A. Islam, et al., “A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results.”, Ophthalmology, 121, 812–821 (2014). doi: 10.1016/j.ophtha.2013.10.028.